Disclosure 0000905148-26-003968-1

SEC FORM 4

$30,969.03

Acrivon Therapeutics, Inc. (ACRV)

Sale of 14,036 shares at $2.2064 per share.

Reporting Persons Blume-Jensen Peter · Masson Kristina · Officer Title President and CEO · Transaction Code S

Traded Aug 25, 2026 · Disclosed Aug 27, 2026

Source: SEC Form 4 · 0000905148-26-003968 · filed 2026-08-27 · View filing →

Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?

Cite this card

Desq Long. "Acrivon Therapeutics, Inc. (ACRV)." Disclosed 2026-08-27. https://desqlong.com/cards/0000905148-26-003968-1 (retrieved 2026-09-26).